Skip to main content

Published locations for CML-CP: Bosutinib outscores imatinib as a frontline treatment option in Asian subpopulation

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CML-CP: Bosutinib outscores imatinib as a frontline treatment option in Asian subpopulation

User login

  • Reset your password
  • /content/cml-cp-bosutinib-outscores-imatinib-frontline-treatment-option-asian-subpopulation
  • /hematology-oncology/article/239655/cml/cml-cp-bosutinib-outscores-imatinib-frontline-treatment